Diag-Nose.io is on a mission to eliminate respiratory disease by decoding the airway’s molecular pathways.
Diag-Nose.io has raised $2.0M in total funding. The most recent round was Grant. The last funding was announced in August 2025.
Diag-Nose.io's investors include Artesian VC, Breakthrough Victoria, Radar Ventures, Specialty Physician Associates, Cooperative Research Centre Projects.
Diag-Nose.io is headquartered in Melbourne, Australia.
Diag-Nose.io is on a mission to eliminate respiratory disease by decoding the airway’s molecular pathways.
Diag-Nose.io is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Diag-Nose.io — Funding & Investors." VCBacked, August 15, 2025, https://www.vcbacked.co/company/diag-noseio. Accessed August 15, 2026.
VCBacked. (2025). Diag-Nose.io — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/diag-noseio
{{cite web |title=Diag-Nose.io — Funding & Investors |url=https://www.vcbacked.co/company/diag-noseio |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated